| Previous close | 6.95 |
| Open | 5.59 |
| Bid | 4.40 |
| Ask | 5.40 |
| Strike | 290.00 |
| Expiry date | 2024-12-20 |
| Day's range | 5.59 - 6.95 |
| Contract range | N/A |
| Volume | |
| Open interest | 7 |
ZacksBAX vs. PODD: Which Stock Should Value Investors Buy Now?
BAX vs. PODD: Which Stock Is the Better Value Option?
Simply Wall St.A Look At The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD)
Key Insights Insulet's estimated fair value is US$206 based on 2 Stage Free Cash Flow to Equity Insulet's US$230 share...
GuruFocus.comInsider Sale: Director Timothy Scannell Sells 5,000 Shares of Insulet Corp (PODD)
Insulet Corp, headquartered in Acton, Massachusetts, is a medical device company primarily engaged in the development, manufacture, and sale of insulin infusion systems for people with insulin-dependent diabetes. Over the past year, Timothy Scannell has sold a total of 15,300 shares of Insulet Corp and has not made any purchases of the stock. Shares of Insulet Corp were trading at $225.84 on the day of the sale.
© 2024 Yahoo. All rights reserved.